Create an Account
  1. Home
  2. CME
  3. Ophthalmology

KOL KNOCKOUT™: Oculoplastics Edition – Sculpting Sight For Patients With Thyroid Eye Disease - Round 1

KOL KNOCKOUT Oculoplastics Edition Sculpting Sight For Patients With Thyroid Eye Disease Round 1
Media formats available:
Details
Presenters

  • Overview

    Step into the ring for the inaugural KOL KNOCKOUT™ in Oculoplastics! Experts Nicholas Robert Mahoney, MD; Amina Malik, MD; and Prem S. Subramanian, MD, PhD, will go head-to-head on thyroid eye disease. With Program Chair Andrew R. Harrison, MD, overseeing the action, this symposium includes fierce competition as they dissect clinical cases and advocate for their preferred management approaches. It's a fight to the finish to see whose strategies reign supreme!

    This content was captured during a synchronous virtual symposium. Voting took place during the symposium.

    This activity is supported by an unrestricted educational grant from Amgen.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Conduct comprehensive clinical assessments, including the appropriate use of laboratory tests and radiologic imaging, to recognize the heterogenous presentation of thyroid eye disease and ascertain potential thyroid dysfunction
    • Propose medically relevant treatment regimens together with customized surgical approaches to address the physical burden and reduced quality of life due to thyroid eye disease
    • Formulate effective comanagement strategies with relevant health care professionals to optimize treatment outcomes and manage adverse events

  • Accreditation

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

  • Faculty and Disclosures

    Andrew R. Harrison, MD

    Andrew R. Harrison, MD

    Professor of Ophthalmology
    and Otolaryngology
    Director, Oculofacial Plastic
    and Orbital Surgery
    Vice Chair, Surgical Services and Quality
    Co-director, Center for Thyroid Eye Disease
    University of Minnesota
    Minneapolis, MN

     

    Nicholas Robert Mahoney, MD

    Nicholas Robert Mahoney, MD

    Chief, Oculoplastics Division
    The Johns Hopkins Hospital
    Associate Professor of Ophthalmology
    Johns Hopkins Wilmer Eye Institute
    Baltimore, MD

     

    Amina Malik, MD

    Amina Malik, MD

    Associate Professor of Clinical Ophthalmology
    Chief of Ophthalmic Plastic and Reconstructive Surgery
    Houston Methodist Hospital
    Weill Cornell Medical College
    Houston, TX

     

    Prem S. Subramanian, MD, PhD

    Prem S. Subramanian, MD, PhD

    Clifford R. and Janice N. Merrill
    Endowed Chair in Ophthalmology
    Professor of Ophthalmology, Neurology,
    and Neurosurgery
    Vice Chair for Academic Affairs
    Sue Anschutz-Rodgers
    University of Colorado Eye Center
    Aurora, CO

     

    DISCLOSURE POLICY
    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

    The following faculty/staff members have the following financial relationships with ineligible companies.

    Andrew R. Harrison, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Horizon Therapeutics, Lassen Therapeutics, RVL, and Viridian Therapeutics. Grant/Research Support: Viridian Therapeutics. Speaker's Bureau: Amgen, Horizon Therapeutics, and RVL.

    Nicholas Robert Mahoney, MD, has had no financial relationships or affiliations with ineligible companies.

    Amina Malik, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.

    Prem S. Subramanian, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Alexion, GenSight Biologics, Horizon Therapeutics, Invex Therapeutics, Kriya Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Advisory Board: GenSight Biologics, Horizon Therapeutics, Immunovant, Invex Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Grant/Research Support: Department of Defense, Horizon Therapeutics, and National Institutes of Health. 

    The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    This content was captured during a synchronous virtual symposium. Voting took place during the symposium.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying Eye Health Academy…
    but how about a more personalized experience?

    Register for free